Physician profile
Ashish Patel
NPI 1083625909
$2,363.50
in general payments reported to CMS, 2019-2025
16 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $496 · 2021: $341 · 2022: $413 · 2023: $278 · 2024: $223 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $382.90 | 2020-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $324.72 | 2019-2022 | |
| Intuitive Surgical, INC. | $250.00 | 2019 | |
| Amgen INC. | $200.47 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $169.71 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $147.18 | 2023 | Jardiance, Mounjaro, Trulicity |
| E.R. Squibb & Sons, L.L.C. | $124.49 | 2025 | Opdivo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.98 | 2021 | |
| Edwards Lifesciences Corporation | $115.27 | 2024 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $107.72 | 2021 | |
| Sanofi-Aventis U.S. LLC | $106.48 | 2022 | |
| Nuvasive, INC. | $103.69 | 2022 | |
| Idorsia Pharmaceuticals US INC | $92.55 | 2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $85.30 | 2022 | |
| Medtronic, INC. | $20.60 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.44 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.